Unexpected disruption to clinical trials, such as that seen in the global COVID-19 pandemic, can have a devastating impact on patients and healthcare systems and cause numerous unforeseen challenges for developers of medicines, medical diagnostics and devices. At Exploristics, they offer a unique package of statistical expertise and tools to address issues arising from the current situation, helping healthcare and life sciences organisations overcome the challenge and getting trials back on track.

Find more information here.